Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-Mar-24 4:33 PM View:  | Flavin John L Director | Pyxis Oncology, Inc. (PYXS) | 26-Mar-24 | Grant | 35,219 | -- | -- | 9% 377.8K to 413.01K | |
| 28-Mar-24 4:32 PM View: | Dupont Jakob Director | Pyxis Oncology, Inc. (PYXS) | 26-Mar-24 | Grant | 38,741 | -- | -- | 100% 0 to 38.74K | |
| 28-Mar-24 4:32 PM View: | Humphrey Rachel Director | Pyxis Oncology, Inc. (PYXS) | 26-Mar-24 | Grant | 38,741 | -- | -- | 67% 58.06K to 96.81K | |
| 28-Mar-24 4:31 PM View: | Wadhane Jitendra SVP, Chief Accounting Officer | Pyxis Oncology, Inc. (PYXS) | 26-Mar-24 | Grant | 131,484 | -- | -- | 49% 266.94K to 398.42K | |
| 28-Mar-24 4:32 PM View: | Lewis-Hall Freda C Director | Pyxis Oncology, Inc. (PYXS) | 26-Mar-24 | Grant | 35,219 | -- | -- | 17% 206.19K to 241.41K | |
| 28-Mar-24 4:33 PM View: | Yanchik Connealy Pamela CFO & COO | Pyxis Oncology, Inc. (PYXS) | 26-Mar-24 | Grant | 328,710 | -- | -- | 42% 781.58K to 1.11M | |
| 28-Mar-24 4:33 PM View: | Cline Darren S Director | Pyxis Oncology, Inc. (PYXS) | 26-Mar-24 | Grant | 35,219 | -- | -- | 16% 216.19K to 251.41K | |
| 30-Nov-23 4:15 PM View: | Yanchik Connealy Pamela CFO and COO | Pyxis Oncology, Inc. (PYXS) | 29-Nov-23 | Payment of Exercise | 36,949 | $1.40 | $51,728.60 | (5%) 818.53K to 781.58K | |
| 17-Nov-23 4:16 PM View: | Wadhane Jitendra Chief Accounting Officer | Pyxis Oncology, Inc. (PYXS) | 15-Nov-23 | Grant | 40,000 | -- | -- | 18% 226.94K to 266.94K | |
| 28-Sep-23 4:32 PM View: | Yanchik Connealy Pamela CFO and COO | Pyxis Oncology, Inc. (PYXS) | 28-Sep-23 | Private Purchase | 8,000 | $1.87 | $14,960.00 | < 1% 810.53K to 818.53K | |
| 27-Sep-23 6:37 PM View: | Wadhane Jitendra Chief Accounting Officer | Pyxis Oncology, Inc. (PYXS) | 27-Sep-23 | Private Purchase | 2,500 | $1.87 | $4,675.00 | 1% 224.44K to 226.94K | |
| 27-Sep-23 6:36 PM View: | Yanchik Connealy Pamela CFO and COO | Pyxis Oncology, Inc. (PYXS) | 27-Sep-23 | Private Purchase | 6,426 | $1.85 | $11,867.50 | < 1% 804.11K to 810.53K | |
| 25-Sep-23 5:05 PM View: | Wadhane Jitendra Chief Accounting Officer | Pyxis Oncology, Inc. (PYXS) | 25-Sep-23 | Private Purchase | 5,000 | $1.77 | $8,850.00 | 2% 219.44K to 224.44K | |
| 25-Sep-23 5:04 PM View: | Yanchik Connealy Pamela CFO and COO | Pyxis Oncology, Inc. (PYXS) | 25-Sep-23 | Private Purchase | 12,000 | $1.67 | $20,043.60 | 2% 792.11K to 804.11K | |
| 22-Sep-23 7:35 PM View: | Wadhane Jitendra Chief Accounting Officer | Pyxis Oncology, Inc. (PYXS) | 22-Sep-23 | Private Purchase | 2,500 | $1.74 | $4,349.25 | 1% 216.94K to 219.44K | |
| 22-Sep-23 7:34 PM View: | Yanchik Connealy Pamela CFO and COO | Pyxis Oncology, Inc. (PYXS) | 22-Sep-23 | Private Purchase | 5,000 | $1.74 | $8,695.00 | < 1% 787.11K to 792.11K | |
| 18-Sep-23 7:03 PM View: | Sullivan Lara President and CEO Director | Pyxis Oncology, Inc. (PYXS) | 18-Sep-23 | Sale | 8,541 | $2.10 | $17,936.10 | (< 1%) 2.41M to 2.4M | |
| 18-Sep-23 7:03 PM View: | Sullivan Lara President and CEO Director | Pyxis Oncology, Inc. (PYXS) | 14-Sep-23 | Sale | 100 | $2.25 | $225.00 | (< 1%) 2.41M to 2.41M | |
| 13-Sep-23 8:16 PM View: | Sullivan Lara President and CEO Director | Pyxis Oncology, Inc. (PYXS) | 13-Sep-23 | Payment of Exercise | 184,742 | $2.13 | $393,500.00 | (7%) 2.6M to 2.42M | |
| 13-Sep-23 8:16 PM View: | Sullivan Lara President and CEO Director | Pyxis Oncology, Inc. (PYXS) | 13-Sep-23 | Sale | 3,000 | $2.27 | $6,815.70 | (< 1%) 2.42M to 2.41M | |
| 13-Sep-23 8:16 PM View: | Sullivan Lara President and CEO Director | Pyxis Oncology, Inc. (PYXS) | 12-Sep-23 | Sale | 4,917 | $2.25 | $11,071.10 | (< 1%) 2.61M to 2.6M | |
| 13-Sep-23 8:16 PM View: | Sullivan Lara President and CEO Director | Pyxis Oncology, Inc. (PYXS) | 11-Sep-23 | Sale | 20,000 | $2.27 | $45,414.00 | (< 1%) 2.63M to 2.61M | |
| 08-Sep-23 5:01 PM View: | Wadhane Jitendra Chief Accounting Officer | Pyxis Oncology, Inc. (PYXS) | 07-Sep-23 | Grant | 93,896 | -- | -- | 80% 118.04K to 211.94K | |
| 08-Sep-23 5:02 PM View: | Yanchik Connealy Pamela CFO and COO | Pyxis Oncology, Inc. (PYXS) | 07-Sep-23 | Grant | 187,793 | -- | -- | 32% 594.31K to 782.11K | |
| 08-Sep-23 5:00 PM View: | Sullivan Lara President and CEO Director | Pyxis Oncology, Inc. (PYXS) | 07-Sep-23 | Grant | 469,483 | -- | -- | 22% 2.16M to 2.63M | |
| 28-Mar-23 4:44 PM View: | Lewis-Hall Freda C Director | Pyxis Oncology, Inc. (PYXS) | 24-Mar-23 | Grant | 139,355 | -- | -- | 209% 66.83K to 206.19K | |
| 28-Mar-23 4:48 PM View: | Sullivan Lara President and CEO Director | Pyxis Oncology, Inc. (PYXS) | 24-Mar-23 | Grant | 703,379 | -- | -- | 48% 1.45M to 2.16M | |
| 28-Mar-23 4:41 PM View: | Civik Thomas Director | Pyxis Oncology, Inc. (PYXS) | 24-Mar-23 | Grant | 139,355 | -- | -- | 169% 82.53K to 221.89K | |
| 28-Mar-23 4:41 PM View: | Cline Darren S Director | Pyxis Oncology, Inc. (PYXS) | 24-Mar-23 | Grant | 139,355 | -- | -- | 181% 76.83K to 216.19K | |
| 28-Mar-23 4:45 PM View: | Feingold Jay Chief Medical Officer | Pyxis Oncology, Inc. (PYXS) | 24-Mar-23 | Grant | 209,803 | -- | -- | 40% 520.54K to 730.35K | |
| 28-Mar-23 4:43 PM View: | Flavin John L Director | Pyxis Oncology, Inc. (PYXS) | 24-Mar-23 | Grant | 139,355 | -- | -- | 58% 238.44K to 377.8K | |
| 28-Mar-23 4:43 PM View: | Humphrey Rachel Director | Pyxis Oncology, Inc. (PYXS) | 24-Mar-23 | Grant | 58,064 | -- | -- | 100% 0 to 58.06K | |
| 28-Mar-23 4:45 PM View: | Wadhane Jitendra Chief Accounting Officer | Pyxis Oncology, Inc. (PYXS) | 24-Mar-23 | Grant | 74,393 | -- | -- | 522% 14.26K to 88.65K | |
| 28-Mar-23 4:47 PM View: | Yanchik Connealy Pamela CFO and COO | Pyxis Oncology, Inc. (PYXS) | 24-Mar-23 | Grant | 209,803 | -- | -- | 55% 384.51K to 594.31K | |
| 21-Mar-23 6:07 PM View: | Pfizer Inc 10% Owner | Pyxis Oncology, Inc. (PYXS) | 17-Mar-23 | Private Purchase | 1,811,590 | $2.76 | $5,000,000.00 | 35% 5.22M to 7.03M | |
| 03-Jan-23 7:39 PM View: | Sullivan Lara Chief Executive Officer Director | Pyxis Oncology, Inc. (PYXS) | 03-Jan-23 | Grant | 95,684 | -- | -- | 7% 1.36M to 1.45M | |
| 03-Jan-23 7:38 PM View: | Feingold Jay Chief Medical Officer | Pyxis Oncology, Inc. (PYXS) | 03-Jan-23 | Grant | 53,931 | -- | -- | 12% 466.61K to 520.54K | |
| 03-Jan-23 7:37 PM View: | Yanchik Connealy Pamela Chief Financial Officer | Pyxis Oncology, Inc. (PYXS) | 03-Jan-23 | Grant | 43,493 | -- | -- | 13% 341.02K to 384.51K | |
| 25-Apr-22 12:12 PM View: | Chin Mark | Pyxis Oncology, Inc. (PYXS) | 21-Apr-22 | Sale | 1,745,760 | $3.05 | $5,324,570.00 | (100%) 1.75M to 0 | |
| 15-Apr-22 8:00 PM View: | Yanchik Connealy Pamela Chief Financial Officer | Pyxis Oncology, Inc. (PYXS) | 14-Apr-22 | Grant | 93,493 | -- | -- | 38% 247.52K to 341.02K | |
| 15-Apr-22 7:56 PM View: | Sullivan Lara Chief Executive Officer Director | Pyxis Oncology, Inc. (PYXS) | 14-Apr-22 | Grant | 315,273 | -- | -- | 30% 1.04M to 1.36M | |
| 15-Apr-22 7:58 PM View: | Feingold Jay Chief Medical Officer | Pyxis Oncology, Inc. (PYXS) | 14-Apr-22 | Grant | 115,931 | -- | -- | 33% 350.68K to 466.61K | |
| 04-Apr-22 10:00 PM View: | Sullivan Lara Chief Executive Officer Director | Pyxis Oncology, Inc. (PYXS) | 31-Mar-22 | Grant | 742,574 | -- | -- | 249% 298.79K to 1.04M | |
| 04-Apr-22 4:16 PM View: | Feingold Jay Chief Medical Officer | Pyxis Oncology, Inc. (PYXS) | 31-Mar-22 | Grant | 306,930 | -- | -- | 702% 43.75K to 350.68K | |
| 04-Apr-22 10:00 PM View: | Chin Mark Director | Pyxis Oncology, Inc. (PYXS) | 31-Mar-22 | Grant | 66,831 | -- | -- | 4% 1.75M to 1.81M | |
| 04-Apr-22 10:00 PM View: | Civik Thomas Director | Pyxis Oncology, Inc. (PYXS) | 31-Mar-22 | Grant | 66,831 | -- | -- | 426% 15.7K to 82.53K | |
| 04-Apr-22 4:15 PM View: | Lewis-Hall Freda C Director | Pyxis Oncology, Inc. (PYXS) | 31-Mar-22 | Grant | 66,831 | -- | -- | 100% 0 to 66.83K | |
| 04-Apr-22 4:15 PM View: | Yanchik Connealy Pamela Chief Financial Officer | Pyxis Oncology, Inc. (PYXS) | 31-Mar-22 | Grant | 247,524 | -- | -- | 100% 0 to 247.52K | |
| 04-Apr-22 10:00 PM View: | Cline Darren S Director | Pyxis Oncology, Inc. (PYXS) | 31-Mar-22 | Grant | 66,831 | -- | -- | 668% 10.0K to 76.83K | |
| 04-Apr-22 4:16 PM View: | Flavin John L Director | Pyxis Oncology, Inc. (PYXS) | 31-Mar-22 | Grant | 66,831 | -- | -- | 39% 171.61K to 238.44K |
